Emma Cohen

I'll research this attorney before drafting.

Emma Cohen — Associate, Greenberg Traurig LLP (New York) · IP litigation

Focus areas. Her Greenberg Traurig bio describes a broad IP litigation practice covering patent, trademark, copyright, and trade secret disputes, with complex patent litigation experience in ANDA/Hatch-Waxman matters, electronics, and software-based technologies. Her tracked docket work, however, is concentrated in a different field: medical devices for treating nasal airway obstruction and chronic rhinitis. All five tracked appearances arise from the Aerin Medical / The Foundry, LLC v. Neurent Medical competitors' dispute over radiofrequency ablation systems (Aerin's VivAer/RhinAer stylus devices versus Neurent's Neuromark system), litigated in D. Del. and at the PTAB. I found no documented Wi-Fi/standards, pharmaceutical (other than the bio's general ANDA reference), or mechanical-arts work for her.

Side preference. The structured counts show 2 plaintiff-side and 3 defendant-side appearances, but the underlying alignment is consistent: Greenberg Traurig represents Aerin Medical Inc. and The Foundry, LLC — the patent owners and asserting parties — against Neurent Medical in this family (e.g., Aerin Med. Inc. v. Neurent Med. Inc., No. 1:23-cv-00756-JLH (D. Del.), and Neurent Med. Ltd. v. Aerin Med. Inc., No. 1:24-cv-01070-JLH, consolidated). The "defendant" labels in the trackers largely reflect captions in the consolidated/PTAB dockets where Aerin or Foundry is the responding party. This is competitor-versus-competitor, operating-company litigation, not NPE/PAE assertion work; her roles are junior (counsel, back-up/backup counsel), consistent with an associate of her vintage.

Notable matters and PTAB/IPR activity. She is named back-up counsel (noted "pro hac vice forthcoming," i.e., not a registered PTAB practitioner) on the four June 2025 IPR petitions Aerin filed against Neurent's patents — IPR2025-01124, -01125, -01126, and -01127 (U.S. Pat. Nos. 11,998,262; 12,089,889; 12,096,973; 12,096,974), alongside Greenberg Traurig's Heath Briggs, Benjamin Gilford, Trenton Ward, Elana Araj, and Declan Stone-Murphy. Those Aerin-side petitions were denied institution by way of discretionary denial in the fall of 2025 (the family was among 21 IPRs resolved by a summary Director notice dated Nov. 6, 2025; IPR2025-01125 shows a Nov. 20, 2025 institution-decision date and "discretionary denial" status). She is not listed on the earlier IPR2024-00277/-00278/-00279/-00280/-00282/-00669 proceedings, in which Neurent challenged Aerin/Foundry patents and the Board (FWDs of July 11 and July 21, 2025) held all challenged claims unpatentable; Aerin appealed those decisions to the Federal Circuit (Nos. 25-2099, -2100, -2101, filed Sept. 12, 2025; pending as of this writing). Aerin also statutorily disclaimed the asserted claims of the '597 and '194 patents in October 2024 as part of that fight. No verdicts, settlements, or argued appeals are attributable to her personally in the sources reviewed.

Firm and credentials. She has been at Greenberg Traurig throughout her tracked appearances (New York office, One Vanderbilt Avenue); no prior law firm history is documented. Before her legal career she worked as a contract paralegal at Campaign Monitor (2021) and as a judicial extern for Chief Judge Philip A. Brimmer (D. Colo., 2023) and a student patent attorney in University of Colorado Law's Entrepreneurial Law Clinic USPTO program (2022–23). She holds a J.D. from the University of Colorado Law School (2024; Lead Note Editor, Colorado Technology Law Journal) and a B.A. in Chemistry from CU Boulder (2021). Her firm bio lists admission in New York; third-party directories (Martindale, Lawyers.com) also list Connecticut and a "first admission" year of 2019, which is inconsistent with a 2024 J.D. and appears to be a data error — treat the admission dates as unverified.